nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Pruritus—Conjugated Estrogens—prostate cancer	0.000978	0.000978	CcSEcCtD
Gadoteridol—Ill-defined disorder—Etoposide—prostate cancer	0.000975	0.000975	CcSEcCtD
Gadoteridol—Rhinitis—Capecitabine—prostate cancer	0.000974	0.000974	CcSEcCtD
Gadoteridol—Hypotension—Mitoxantrone—prostate cancer	0.000963	0.000963	CcSEcCtD
Gadoteridol—Diarrhoea—Goserelin—prostate cancer	0.000955	0.000955	CcSEcCtD
Gadoteridol—Malaise—Etoposide—prostate cancer	0.000948	0.000948	CcSEcCtD
Gadoteridol—Pain—Estradiol—prostate cancer	0.000946	0.000946	CcSEcCtD
Gadoteridol—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000946	0.000946	CcSEcCtD
Gadoteridol—Face oedema—Epirubicin—prostate cancer	0.000944	0.000944	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000935	0.000935	CcSEcCtD
Gadoteridol—Flushing—Docetaxel—prostate cancer	0.000931	0.000931	CcSEcCtD
Gadoteridol—Cardiac arrest—Epirubicin—prostate cancer	0.00093	0.00093	CcSEcCtD
Gadoteridol—Paraesthesia—Mitoxantrone—prostate cancer	0.000926	0.000926	CcSEcCtD
Gadoteridol—Loss of consciousness—Etoposide—prostate cancer	0.000924	0.000924	CcSEcCtD
Gadoteridol—Dizziness—Goserelin—prostate cancer	0.000923	0.000923	CcSEcCtD
Gadoteridol—Dyspnoea—Mitoxantrone—prostate cancer	0.000919	0.000919	CcSEcCtD
Gadoteridol—Cough—Etoposide—prostate cancer	0.000917	0.000917	CcSEcCtD
Gadoteridol—Dizziness—Conjugated Estrogens—prostate cancer	0.000914	0.000914	CcSEcCtD
Gadoteridol—Feeling abnormal—Estradiol—prostate cancer	0.000912	0.000912	CcSEcCtD
Gadoteridol—Convulsion—Etoposide—prostate cancer	0.00091	0.00091	CcSEcCtD
Gadoteridol—Hypertension—Etoposide—prostate cancer	0.000907	0.000907	CcSEcCtD
Gadoteridol—Tinnitus—Capecitabine—prostate cancer	0.000906	0.000906	CcSEcCtD
Gadoteridol—Flushing—Capecitabine—prostate cancer	0.000901	0.000901	CcSEcCtD
Gadoteridol—Chest pain—Etoposide—prostate cancer	0.000895	0.000895	CcSEcCtD
Gadoteridol—Vomiting—Goserelin—prostate cancer	0.000887	0.000887	CcSEcCtD
Gadoteridol—Discomfort—Etoposide—prostate cancer	0.000884	0.000884	CcSEcCtD
Gadoteridol—Pain—Mitoxantrone—prostate cancer	0.000882	0.000882	CcSEcCtD
Gadoteridol—Bradycardia—Prednisone—prostate cancer	0.000881	0.000881	CcSEcCtD
Gadoteridol—Rash—Goserelin—prostate cancer	0.00088	0.00088	CcSEcCtD
Gadoteridol—Dermatitis—Goserelin—prostate cancer	0.000879	0.000879	CcSEcCtD
Gadoteridol—Vomiting—Conjugated Estrogens—prostate cancer	0.000879	0.000879	CcSEcCtD
Gadoteridol—Urticaria—Estradiol—prostate cancer	0.000879	0.000879	CcSEcCtD
Gadoteridol—Abdominal pain—Estradiol—prostate cancer	0.000875	0.000875	CcSEcCtD
Gadoteridol—Body temperature increased—Estradiol—prostate cancer	0.000875	0.000875	CcSEcCtD
Gadoteridol—Headache—Goserelin—prostate cancer	0.000874	0.000874	CcSEcCtD
Gadoteridol—Face oedema—Doxorubicin—prostate cancer	0.000874	0.000874	CcSEcCtD
Gadoteridol—Erythema—Docetaxel—prostate cancer	0.000873	0.000873	CcSEcCtD
Gadoteridol—Rash—Conjugated Estrogens—prostate cancer	0.000872	0.000872	CcSEcCtD
Gadoteridol—Dermatitis—Conjugated Estrogens—prostate cancer	0.000871	0.000871	CcSEcCtD
Gadoteridol—Headache—Conjugated Estrogens—prostate cancer	0.000866	0.000866	CcSEcCtD
Gadoteridol—Cardiac arrest—Doxorubicin—prostate cancer	0.000861	0.000861	CcSEcCtD
Gadoteridol—Anaphylactic shock—Etoposide—prostate cancer	0.000858	0.000858	CcSEcCtD
Gadoteridol—Dysgeusia—Docetaxel—prostate cancer	0.000855	0.000855	CcSEcCtD
Gadoteridol—Feeling abnormal—Mitoxantrone—prostate cancer	0.00085	0.00085	CcSEcCtD
Gadoteridol—Erythema—Capecitabine—prostate cancer	0.000845	0.000845	CcSEcCtD
Gadoteridol—Dysphagia—Epirubicin—prostate cancer	0.000845	0.000845	CcSEcCtD
Gadoteridol—Nausea—Goserelin—prostate cancer	0.000829	0.000829	CcSEcCtD
Gadoteridol—Hyperhidrosis—Etoposide—prostate cancer	0.000829	0.000829	CcSEcCtD
Gadoteridol—Dysgeusia—Capecitabine—prostate cancer	0.000828	0.000828	CcSEcCtD
Gadoteridol—Nausea—Conjugated Estrogens—prostate cancer	0.000821	0.000821	CcSEcCtD
Gadoteridol—Urticaria—Mitoxantrone—prostate cancer	0.000819	0.000819	CcSEcCtD
Gadoteridol—Hypersensitivity—Estradiol—prostate cancer	0.000815	0.000815	CcSEcCtD
Gadoteridol—Body temperature increased—Mitoxantrone—prostate cancer	0.000815	0.000815	CcSEcCtD
Gadoteridol—Abdominal pain—Mitoxantrone—prostate cancer	0.000815	0.000815	CcSEcCtD
Gadoteridol—Flushing—Prednisone—prostate cancer	0.000803	0.000803	CcSEcCtD
Gadoteridol—Hypotension—Etoposide—prostate cancer	0.000801	0.000801	CcSEcCtD
Gadoteridol—Tremor—Capecitabine—prostate cancer	0.000792	0.000792	CcSEcCtD
Gadoteridol—Ill-defined disorder—Capecitabine—prostate cancer	0.000784	0.000784	CcSEcCtD
Gadoteridol—Syncope—Docetaxel—prostate cancer	0.000783	0.000783	CcSEcCtD
Gadoteridol—Pruritus—Estradiol—prostate cancer	0.000783	0.000783	CcSEcCtD
Gadoteridol—Dysphagia—Doxorubicin—prostate cancer	0.000782	0.000782	CcSEcCtD
Gadoteridol—Paraesthesia—Etoposide—prostate cancer	0.00077	0.00077	CcSEcCtD
Gadoteridol—Loss of consciousness—Docetaxel—prostate cancer	0.000768	0.000768	CcSEcCtD
Gadoteridol—Dyspnoea—Etoposide—prostate cancer	0.000765	0.000765	CcSEcCtD
Gadoteridol—Malaise—Capecitabine—prostate cancer	0.000762	0.000762	CcSEcCtD
Gadoteridol—Cough—Docetaxel—prostate cancer	0.000762	0.000762	CcSEcCtD
Gadoteridol—Hypersensitivity—Mitoxantrone—prostate cancer	0.00076	0.00076	CcSEcCtD
Gadoteridol—Syncope—Capecitabine—prostate cancer	0.000758	0.000758	CcSEcCtD
Gadoteridol—Diarrhoea—Estradiol—prostate cancer	0.000757	0.000757	CcSEcCtD
Gadoteridol—Convulsion—Docetaxel—prostate cancer	0.000757	0.000757	CcSEcCtD
Gadoteridol—Hypertension—Docetaxel—prostate cancer	0.000754	0.000754	CcSEcCtD
Gadoteridol—Erythema—Prednisone—prostate cancer	0.000753	0.000753	CcSEcCtD
Gadoteridol—Chest pain—Docetaxel—prostate cancer	0.000743	0.000743	CcSEcCtD
Gadoteridol—Loss of consciousness—Capecitabine—prostate cancer	0.000743	0.000743	CcSEcCtD
Gadoteridol—Cough—Capecitabine—prostate cancer	0.000738	0.000738	CcSEcCtD
Gadoteridol—Pain—Etoposide—prostate cancer	0.000733	0.000733	CcSEcCtD
Gadoteridol—Dizziness—Estradiol—prostate cancer	0.000732	0.000732	CcSEcCtD
Gadoteridol—Hypertension—Capecitabine—prostate cancer	0.00073	0.00073	CcSEcCtD
Gadoteridol—Dry mouth—Docetaxel—prostate cancer	0.000727	0.000727	CcSEcCtD
Gadoteridol—Sweating—Epirubicin—prostate cancer	0.000723	0.000723	CcSEcCtD
Gadoteridol—Chest pain—Capecitabine—prostate cancer	0.00072	0.00072	CcSEcCtD
Gadoteridol—Anxiety—Capecitabine—prostate cancer	0.000717	0.000717	CcSEcCtD
Gadoteridol—Anaphylactic shock—Docetaxel—prostate cancer	0.000713	0.000713	CcSEcCtD
Gadoteridol—Oedema—Docetaxel—prostate cancer	0.000713	0.000713	CcSEcCtD
Gadoteridol—Discomfort—Capecitabine—prostate cancer	0.000711	0.000711	CcSEcCtD
Gadoteridol—Feeling abnormal—Etoposide—prostate cancer	0.000707	0.000707	CcSEcCtD
Gadoteridol—Diarrhoea—Mitoxantrone—prostate cancer	0.000705	0.000705	CcSEcCtD
Gadoteridol—Dry mouth—Capecitabine—prostate cancer	0.000704	0.000704	CcSEcCtD
Gadoteridol—Vomiting—Estradiol—prostate cancer	0.000704	0.000704	CcSEcCtD
Gadoteridol—Shock—Docetaxel—prostate cancer	0.000701	0.000701	CcSEcCtD
Gadoteridol—Ill-defined disorder—Prednisone—prostate cancer	0.000699	0.000699	CcSEcCtD
Gadoteridol—Rash—Estradiol—prostate cancer	0.000698	0.000698	CcSEcCtD
Gadoteridol—Dermatitis—Estradiol—prostate cancer	0.000697	0.000697	CcSEcCtD
Gadoteridol—Headache—Estradiol—prostate cancer	0.000693	0.000693	CcSEcCtD
Gadoteridol—Oedema—Capecitabine—prostate cancer	0.00069	0.00069	CcSEcCtD
Gadoteridol—Bradycardia—Epirubicin—prostate cancer	0.000689	0.000689	CcSEcCtD
Gadoteridol—Urticaria—Etoposide—prostate cancer	0.000681	0.000681	CcSEcCtD
Gadoteridol—Malaise—Prednisone—prostate cancer	0.000679	0.000679	CcSEcCtD
Gadoteridol—Shock—Capecitabine—prostate cancer	0.000679	0.000679	CcSEcCtD
Gadoteridol—Rhinitis—Epirubicin—prostate cancer	0.000678	0.000678	CcSEcCtD
Gadoteridol—Abdominal pain—Etoposide—prostate cancer	0.000678	0.000678	CcSEcCtD
Gadoteridol—Body temperature increased—Etoposide—prostate cancer	0.000678	0.000678	CcSEcCtD
Gadoteridol—Syncope—Prednisone—prostate cancer	0.000675	0.000675	CcSEcCtD
Gadoteridol—Sweating—Doxorubicin—prostate cancer	0.000669	0.000669	CcSEcCtD
Gadoteridol—Hyperhidrosis—Capecitabine—prostate cancer	0.000667	0.000667	CcSEcCtD
Gadoteridol—Hypotension—Docetaxel—prostate cancer	0.000666	0.000666	CcSEcCtD
Gadoteridol—Loss of consciousness—Prednisone—prostate cancer	0.000662	0.000662	CcSEcCtD
Gadoteridol—Nausea—Estradiol—prostate cancer	0.000657	0.000657	CcSEcCtD
Gadoteridol—Vomiting—Mitoxantrone—prostate cancer	0.000656	0.000656	CcSEcCtD
Gadoteridol—Convulsion—Prednisone—prostate cancer	0.000653	0.000653	CcSEcCtD
Gadoteridol—Hypertension—Prednisone—prostate cancer	0.00065	0.00065	CcSEcCtD
Gadoteridol—Rash—Mitoxantrone—prostate cancer	0.00065	0.00065	CcSEcCtD
Gadoteridol—Dermatitis—Mitoxantrone—prostate cancer	0.000649	0.000649	CcSEcCtD
Gadoteridol—Headache—Mitoxantrone—prostate cancer	0.000646	0.000646	CcSEcCtD
Gadoteridol—Hypotension—Capecitabine—prostate cancer	0.000645	0.000645	CcSEcCtD
Gadoteridol—Paraesthesia—Docetaxel—prostate cancer	0.00064	0.00064	CcSEcCtD
Gadoteridol—Anxiety—Prednisone—prostate cancer	0.000639	0.000639	CcSEcCtD
Gadoteridol—Bradycardia—Doxorubicin—prostate cancer	0.000637	0.000637	CcSEcCtD
Gadoteridol—Dyspnoea—Docetaxel—prostate cancer	0.000635	0.000635	CcSEcCtD
Gadoteridol—Discomfort—Prednisone—prostate cancer	0.000633	0.000633	CcSEcCtD
Gadoteridol—Hypersensitivity—Etoposide—prostate cancer	0.000632	0.000632	CcSEcCtD
Gadoteridol—Tinnitus—Epirubicin—prostate cancer	0.000631	0.000631	CcSEcCtD
Gadoteridol—Flushing—Epirubicin—prostate cancer	0.000628	0.000628	CcSEcCtD
Gadoteridol—Rhinitis—Doxorubicin—prostate cancer	0.000628	0.000628	CcSEcCtD
Gadoteridol—Paraesthesia—Capecitabine—prostate cancer	0.00062	0.00062	CcSEcCtD
Gadoteridol—Dyspnoea—Capecitabine—prostate cancer	0.000615	0.000615	CcSEcCtD
Gadoteridol—Oedema—Prednisone—prostate cancer	0.000615	0.000615	CcSEcCtD
Gadoteridol—Anaphylactic shock—Prednisone—prostate cancer	0.000615	0.000615	CcSEcCtD
Gadoteridol—Nausea—Mitoxantrone—prostate cancer	0.000612	0.000612	CcSEcCtD
Gadoteridol—Pain—Docetaxel—prostate cancer	0.000609	0.000609	CcSEcCtD
Gadoteridol—Pruritus—Etoposide—prostate cancer	0.000607	0.000607	CcSEcCtD
Gadoteridol—Shock—Prednisone—prostate cancer	0.000605	0.000605	CcSEcCtD
Gadoteridol—Hyperhidrosis—Prednisone—prostate cancer	0.000594	0.000594	CcSEcCtD
Gadoteridol—Pain—Capecitabine—prostate cancer	0.00059	0.00059	CcSEcCtD
Gadoteridol—Erythema—Epirubicin—prostate cancer	0.000589	0.000589	CcSEcCtD
Gadoteridol—Feeling abnormal—Docetaxel—prostate cancer	0.000587	0.000587	CcSEcCtD
Gadoteridol—Diarrhoea—Etoposide—prostate cancer	0.000587	0.000587	CcSEcCtD
Gadoteridol—Tinnitus—Doxorubicin—prostate cancer	0.000584	0.000584	CcSEcCtD
Gadoteridol—Flushing—Doxorubicin—prostate cancer	0.000581	0.000581	CcSEcCtD
Gadoteridol—Dysgeusia—Epirubicin—prostate cancer	0.000577	0.000577	CcSEcCtD
Gadoteridol—Feeling abnormal—Capecitabine—prostate cancer	0.000569	0.000569	CcSEcCtD
Gadoteridol—Dizziness—Etoposide—prostate cancer	0.000567	0.000567	CcSEcCtD
Gadoteridol—Abdominal pain—Docetaxel—prostate cancer	0.000563	0.000563	CcSEcCtD
Gadoteridol—Body temperature increased—Docetaxel—prostate cancer	0.000563	0.000563	CcSEcCtD
Gadoteridol—Paraesthesia—Prednisone—prostate cancer	0.000552	0.000552	CcSEcCtD
Gadoteridol—Urticaria—Capecitabine—prostate cancer	0.000548	0.000548	CcSEcCtD
Gadoteridol—Ill-defined disorder—Epirubicin—prostate cancer	0.000547	0.000547	CcSEcCtD
Gadoteridol—Abdominal pain—Capecitabine—prostate cancer	0.000545	0.000545	CcSEcCtD
Gadoteridol—Body temperature increased—Capecitabine—prostate cancer	0.000545	0.000545	CcSEcCtD
Gadoteridol—Vomiting—Etoposide—prostate cancer	0.000545	0.000545	CcSEcCtD
Gadoteridol—Erythema—Doxorubicin—prostate cancer	0.000545	0.000545	CcSEcCtD
Gadoteridol—Rash—Etoposide—prostate cancer	0.000541	0.000541	CcSEcCtD
Gadoteridol—Dermatitis—Etoposide—prostate cancer	0.00054	0.00054	CcSEcCtD
Gadoteridol—Headache—Etoposide—prostate cancer	0.000537	0.000537	CcSEcCtD
Gadoteridol—Dysgeusia—Doxorubicin—prostate cancer	0.000534	0.000534	CcSEcCtD
Gadoteridol—Malaise—Epirubicin—prostate cancer	0.000531	0.000531	CcSEcCtD
Gadoteridol—Syncope—Epirubicin—prostate cancer	0.000528	0.000528	CcSEcCtD
Gadoteridol—Hypersensitivity—Docetaxel—prostate cancer	0.000525	0.000525	CcSEcCtD
Gadoteridol—Loss of consciousness—Epirubicin—prostate cancer	0.000518	0.000518	CcSEcCtD
Gadoteridol—Cough—Epirubicin—prostate cancer	0.000514	0.000514	CcSEcCtD
Gadoteridol—Convulsion—Epirubicin—prostate cancer	0.00051	0.00051	CcSEcCtD
Gadoteridol—Nausea—Etoposide—prostate cancer	0.000509	0.000509	CcSEcCtD
Gadoteridol—Hypertension—Epirubicin—prostate cancer	0.000509	0.000509	CcSEcCtD
Gadoteridol—Hypersensitivity—Capecitabine—prostate cancer	0.000508	0.000508	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisone—prostate cancer	0.000507	0.000507	CcSEcCtD
Gadoteridol—Ill-defined disorder—Doxorubicin—prostate cancer	0.000506	0.000506	CcSEcCtD
Gadoteridol—Pruritus—Docetaxel—prostate cancer	0.000504	0.000504	CcSEcCtD
Gadoteridol—Chest pain—Epirubicin—prostate cancer	0.000501	0.000501	CcSEcCtD
Gadoteridol—Anxiety—Epirubicin—prostate cancer	0.0005	0.0005	CcSEcCtD
Gadoteridol—Discomfort—Epirubicin—prostate cancer	0.000495	0.000495	CcSEcCtD
Gadoteridol—Malaise—Doxorubicin—prostate cancer	0.000491	0.000491	CcSEcCtD
Gadoteridol—Dry mouth—Epirubicin—prostate cancer	0.00049	0.00049	CcSEcCtD
Gadoteridol—Syncope—Doxorubicin—prostate cancer	0.000489	0.000489	CcSEcCtD
Gadoteridol—Urticaria—Prednisone—prostate cancer	0.000488	0.000488	CcSEcCtD
Gadoteridol—Pruritus—Capecitabine—prostate cancer	0.000488	0.000488	CcSEcCtD
Gadoteridol—Diarrhoea—Docetaxel—prostate cancer	0.000488	0.000488	CcSEcCtD
Gadoteridol—Abdominal pain—Prednisone—prostate cancer	0.000486	0.000486	CcSEcCtD
Gadoteridol—Body temperature increased—Prednisone—prostate cancer	0.000486	0.000486	CcSEcCtD
Gadoteridol—Oedema—Epirubicin—prostate cancer	0.000481	0.000481	CcSEcCtD
Gadoteridol—Anaphylactic shock—Epirubicin—prostate cancer	0.000481	0.000481	CcSEcCtD
Gadoteridol—Loss of consciousness—Doxorubicin—prostate cancer	0.000479	0.000479	CcSEcCtD
Gadoteridol—Cough—Doxorubicin—prostate cancer	0.000476	0.000476	CcSEcCtD
Gadoteridol—Shock—Epirubicin—prostate cancer	0.000473	0.000473	CcSEcCtD
Gadoteridol—Convulsion—Doxorubicin—prostate cancer	0.000472	0.000472	CcSEcCtD
Gadoteridol—Diarrhoea—Capecitabine—prostate cancer	0.000472	0.000472	CcSEcCtD
Gadoteridol—Dizziness—Docetaxel—prostate cancer	0.000471	0.000471	CcSEcCtD
Gadoteridol—Hypertension—Doxorubicin—prostate cancer	0.000471	0.000471	CcSEcCtD
Gadoteridol—Hyperhidrosis—Epirubicin—prostate cancer	0.000465	0.000465	CcSEcCtD
Gadoteridol—Chest pain—Doxorubicin—prostate cancer	0.000464	0.000464	CcSEcCtD
Gadoteridol—Anxiety—Doxorubicin—prostate cancer	0.000462	0.000462	CcSEcCtD
Gadoteridol—Discomfort—Doxorubicin—prostate cancer	0.000458	0.000458	CcSEcCtD
Gadoteridol—Dizziness—Capecitabine—prostate cancer	0.000456	0.000456	CcSEcCtD
Gadoteridol—Dry mouth—Doxorubicin—prostate cancer	0.000454	0.000454	CcSEcCtD
Gadoteridol—Vomiting—Docetaxel—prostate cancer	0.000453	0.000453	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisone—prostate cancer	0.000453	0.000453	CcSEcCtD
Gadoteridol—Rash—Docetaxel—prostate cancer	0.000449	0.000449	CcSEcCtD
Gadoteridol—Hypotension—Epirubicin—prostate cancer	0.000449	0.000449	CcSEcCtD
Gadoteridol—Dermatitis—Docetaxel—prostate cancer	0.000449	0.000449	CcSEcCtD
Gadoteridol—Headache—Docetaxel—prostate cancer	0.000446	0.000446	CcSEcCtD
Gadoteridol—Oedema—Doxorubicin—prostate cancer	0.000445	0.000445	CcSEcCtD
Gadoteridol—Anaphylactic shock—Doxorubicin—prostate cancer	0.000445	0.000445	CcSEcCtD
Gadoteridol—Vomiting—Capecitabine—prostate cancer	0.000439	0.000439	CcSEcCtD
Gadoteridol—Shock—Doxorubicin—prostate cancer	0.000438	0.000438	CcSEcCtD
Gadoteridol—Rash—Capecitabine—prostate cancer	0.000435	0.000435	CcSEcCtD
Gadoteridol—Pruritus—Prednisone—prostate cancer	0.000435	0.000435	CcSEcCtD
Gadoteridol—Dermatitis—Capecitabine—prostate cancer	0.000435	0.000435	CcSEcCtD
Gadoteridol—Headache—Capecitabine—prostate cancer	0.000432	0.000432	CcSEcCtD
Gadoteridol—Paraesthesia—Epirubicin—prostate cancer	0.000432	0.000432	CcSEcCtD
Gadoteridol—Hyperhidrosis—Doxorubicin—prostate cancer	0.00043	0.00043	CcSEcCtD
Gadoteridol—Dyspnoea—Epirubicin—prostate cancer	0.000429	0.000429	CcSEcCtD
Gadoteridol—Nausea—Docetaxel—prostate cancer	0.000423	0.000423	CcSEcCtD
Gadoteridol—Diarrhoea—Prednisone—prostate cancer	0.000421	0.000421	CcSEcCtD
Gadoteridol—Hypotension—Doxorubicin—prostate cancer	0.000416	0.000416	CcSEcCtD
Gadoteridol—Pain—Epirubicin—prostate cancer	0.000411	0.000411	CcSEcCtD
Gadoteridol—Nausea—Capecitabine—prostate cancer	0.00041	0.00041	CcSEcCtD
Gadoteridol—Dizziness—Prednisone—prostate cancer	0.000406	0.000406	CcSEcCtD
Gadoteridol—Paraesthesia—Doxorubicin—prostate cancer	0.000399	0.000399	CcSEcCtD
Gadoteridol—Dyspnoea—Doxorubicin—prostate cancer	0.000397	0.000397	CcSEcCtD
Gadoteridol—Feeling abnormal—Epirubicin—prostate cancer	0.000396	0.000396	CcSEcCtD
Gadoteridol—Vomiting—Prednisone—prostate cancer	0.000391	0.000391	CcSEcCtD
Gadoteridol—Rash—Prednisone—prostate cancer	0.000388	0.000388	CcSEcCtD
Gadoteridol—Dermatitis—Prednisone—prostate cancer	0.000387	0.000387	CcSEcCtD
Gadoteridol—Headache—Prednisone—prostate cancer	0.000385	0.000385	CcSEcCtD
Gadoteridol—Urticaria—Epirubicin—prostate cancer	0.000382	0.000382	CcSEcCtD
Gadoteridol—Pain—Doxorubicin—prostate cancer	0.00038	0.00038	CcSEcCtD
Gadoteridol—Abdominal pain—Epirubicin—prostate cancer	0.00038	0.00038	CcSEcCtD
Gadoteridol—Body temperature increased—Epirubicin—prostate cancer	0.00038	0.00038	CcSEcCtD
Gadoteridol—Feeling abnormal—Doxorubicin—prostate cancer	0.000367	0.000367	CcSEcCtD
Gadoteridol—Nausea—Prednisone—prostate cancer	0.000365	0.000365	CcSEcCtD
Gadoteridol—Hypersensitivity—Epirubicin—prostate cancer	0.000354	0.000354	CcSEcCtD
Gadoteridol—Urticaria—Doxorubicin—prostate cancer	0.000353	0.000353	CcSEcCtD
Gadoteridol—Body temperature increased—Doxorubicin—prostate cancer	0.000352	0.000352	CcSEcCtD
Gadoteridol—Abdominal pain—Doxorubicin—prostate cancer	0.000352	0.000352	CcSEcCtD
Gadoteridol—Pruritus—Epirubicin—prostate cancer	0.00034	0.00034	CcSEcCtD
Gadoteridol—Diarrhoea—Epirubicin—prostate cancer	0.000329	0.000329	CcSEcCtD
Gadoteridol—Hypersensitivity—Doxorubicin—prostate cancer	0.000328	0.000328	CcSEcCtD
Gadoteridol—Dizziness—Epirubicin—prostate cancer	0.000318	0.000318	CcSEcCtD
Gadoteridol—Pruritus—Doxorubicin—prostate cancer	0.000315	0.000315	CcSEcCtD
Gadoteridol—Vomiting—Epirubicin—prostate cancer	0.000306	0.000306	CcSEcCtD
Gadoteridol—Diarrhoea—Doxorubicin—prostate cancer	0.000304	0.000304	CcSEcCtD
Gadoteridol—Rash—Epirubicin—prostate cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Dermatitis—Epirubicin—prostate cancer	0.000303	0.000303	CcSEcCtD
Gadoteridol—Headache—Epirubicin—prostate cancer	0.000301	0.000301	CcSEcCtD
Gadoteridol—Dizziness—Doxorubicin—prostate cancer	0.000294	0.000294	CcSEcCtD
Gadoteridol—Nausea—Epirubicin—prostate cancer	0.000286	0.000286	CcSEcCtD
Gadoteridol—Vomiting—Doxorubicin—prostate cancer	0.000283	0.000283	CcSEcCtD
Gadoteridol—Rash—Doxorubicin—prostate cancer	0.00028	0.00028	CcSEcCtD
Gadoteridol—Dermatitis—Doxorubicin—prostate cancer	0.00028	0.00028	CcSEcCtD
Gadoteridol—Headache—Doxorubicin—prostate cancer	0.000279	0.000279	CcSEcCtD
Gadoteridol—Nausea—Doxorubicin—prostate cancer	0.000264	0.000264	CcSEcCtD
